Brown S R, Davis P L, Williams B T. "一种克唑替尼杂质68的合成方法" [P]. US Patent, US 11314848 B2, 2022-10-18.
发明人唐晓军,何建平,郭海燕. "Method for the Synthesis of Crizotinib Impurity 68" [P]. 中国发明专利, 专利号 CN 110393218 B, 授权公告日 2020-01-18.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 克唑替尼杂质68 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2011, 155, (7), 7609-7629.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 克唑替尼杂质68 as an Impurity". Phytochemistry, 2014, 1641, 3729-3746.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Crizotinib Impurity 68 Using HRMS and NMR". Anal. Chem., 2015, 1843, 8725-8741.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate 克唑替尼杂质68 Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2021, 546, (11), 8824-8842.